Waverton Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $222K | Hold |
2,000
| – | – | ﹤0.01% | 102 |
|
|
2025
Q1 | $224K | Buy |
+2,000
| New | +$224K | ﹤0.01% | 98 |
|
|
2018
Q2 | – | Sell |
-10,525
| Closed | -$793K | – | 74 |
|
|
2018
Q1 | $793K | Hold |
10,525
| – | – | 0.05% | 65 |
|
|
2017
Q4 | $754K | Hold |
10,525
| – | – | 0.04% | 67 |
|
|
2017
Q3 | $853K | Buy |
10,525
+101
| +1% | +$8.19K | 0.05% | 55 |
|
|
2017
Q2 | $738K | Sell |
10,424
-1,262
| -11% | -$89.3K | 0.05% | 65 |
|
|
2017
Q1 | $794K | Sell |
11,686
-1,011,603
| -99% | -$68.7M | 0.05% | 78 |
|
|
2016
Q4 | $73.3M | Buy |
1,023,289
+35,506
| +4% | +$2.54M | 4.8% | 4 |
|
|
2016
Q3 | $78.2M | Buy |
987,783
+92,512
| +10% | +$7.32M | 5.26% | 4 |
|
|
2016
Q2 | $74.7M | Buy |
895,271
+4,776
| +0.5% | +$398K | 5.61% | 2 |
|
|
2016
Q1 | $81.8M | Buy |
890,495
+34,434
| +4% | +$3.16M | 6.26% | 2 |
|
|
2015
Q4 | $86.6M | Buy |
856,061
+61,455
| +8% | +$6.22M | 6.52% | 1 |
|
|
2015
Q3 | $78M | Buy |
794,606
+31,154
| +4% | +$3.06M | 6.24% | 2 |
|
|
2015
Q2 | $89.4M | Buy |
763,452
+123,984
| +19% | +$14.5M | 6.62% | 1 |
|
|
2015
Q1 | $62.8M | Sell |
639,468
-5,548
| -0.9% | -$544K | 4.5% | 7 |
|
|
2014
Q4 | $60.8M | Buy |
645,016
+112,926
| +21% | +$10.6M | 4.2% | 6 |
|
|
2014
Q3 | $56.6M | Buy |
532,090
+108,111
| +25% | +$11.5M | 3.9% | 6 |
|
|
2014
Q2 | $35.2M | Buy |
423,979
+267,129
| +170% | +$22.1M | 2.3% | 13 |
|
|
2014
Q1 | $11.1M | Buy |
156,850
+650
| +0.4% | +$46.1K | 0.53% | 41 |
|
|
2013
Q4 | $11.7M | Buy |
+156,200
| New | +$11.7M | 0.6% | 36 |
|